Cargando…

MDFI is a novel biomarker for poor prognosis in LUAD

BACKGROUND: Approximately 80% of lung cancers are non-small cell lung cancers (NSCLC). Lung adenocarcinoma (LUAD) is the main subtype of NSCLC. The incidence and mortality of lung cancer are also increasing yearly. Myogenic differentiation family inhibitor (MDFI) as a transcription factor, its role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Pengyu, Quan, Zhen, Song, Xueyu, Gao, Zhaojia, Yuan, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589366/ https://www.ncbi.nlm.nih.gov/pubmed/36300089 http://dx.doi.org/10.3389/fonc.2022.1005962

Ejemplares similares

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling
por: Chen, Hao, et al.
Publicado: (2022)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer
por: Sui, Yuan, et al.
Publicado: (2020)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
por: Liu, Yang, et al.
Publicado: (2022)

TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
por: Lou, Ming, et al.
Publicado: (2020)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
por: Sun, Xinti, et al.
Publicado: (2022)

Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65
por: Ma, Hongying, et al.
Publicado: (2018)

ACAN, MDFI, and CHST1 as Candidate Genes in Gastric Cancer: A Comprehensive Insilco Analysis
por: Vafaeie, Farzane, et al.
Publicado: (2022)

High serum mannose in colorectal cancer: a novel biomarker of lymph node metastasis and poor prognosis
por: Wang, Xueling, et al.
Publicado: (2023)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases
por: Zhang, Lili, et al.
Publicado: (2022)

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
por: Zhang, Ling, et al.
Publicado: (2021)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer
por: Fang, Zheng, et al.
Publicado: (2022)

Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
por: Zhang, Jieru, et al.
Publicado: (2020)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT
por: Jing, Pengyu, et al.
Publicado: (2020)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer
por: Wu, Jialing, et al.
Publicado: (2021)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis
por: Lin, Zhijie, et al.
Publicado: (2022)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD
por: Tian, Baorui, et al.
Publicado: (2020)

Mdfi Promotes C2C12 Cell Differentiation and Positively Modulates Fast-to-Slow-Twitch Muscle Fiber Transformation
por: Huang, Bo, et al.
Publicado: (2021)

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis
por: Liu, Yu, et al.
Publicado: (2020)

Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer
por: Gao, Song, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s1jfs0ojlvljvubc2vue98higt